Cargando…
N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer
BACKGROUND: N6-methyladenosine (m(6)A) modification has been widely studied in various cancers, and m(6)A regulators, such as METTL3, METTL14, WTAP, and YTHDF1, play crucial roles in breast cancer. However, a comprehensive study of m(6)A regulators in breast cancer is still lacking. MATERIAL/METHODS...
Autores principales: | Song, Yanni, Zheng, Chaojing, Tao, Yangbao, Huang, Rui, Zhang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353996/ https://www.ncbi.nlm.nih.gov/pubmed/34349094 http://dx.doi.org/10.12659/MSM.929615 |
Ejemplares similares
-
RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance
por: Zhao, Hua, et al.
Publicado: (2021) -
A Prognostic Molecular Signature of N(6)-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database
por: Hou, Mingming, et al.
Publicado: (2020) -
REPIC: a database for exploring the N(6)-methyladenosine methylome
por: Liu, Shun, et al.
Publicado: (2020) -
m(6)A-Atlas: a comprehensive knowledgebase for unraveling the N(6)-methyladenosine (m(6)A) epitranscriptome
por: Tang, Yujiao, et al.
Publicado: (2020) -
Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients
por: Liu, Xinyu, et al.
Publicado: (2021)